FCF Grants Awarded to University of California at San Francisco

Total grants: 6

• Cellular and in vivo evaluation of DNAJ-PKAc modulator action — Principal investigator(s): John Gordan — 2025
• Selective translational inhibition as a treatment strategy for fibrolamellar liver cancer — Principal investigator(s): John Gordan — 2023
• Defining incidence of fibrolamellar carcinoma through computational analysis of multiple data types — Principal investigator(s): John Gordan — 2021
• Targeting DNAJB1-PRKACA driven signaling dependencies in FLC — Principal investigator(s): John Gordan, Nabeel Bardeesy — 2019
• Flipping the switch on PKA: synthetic lethal approaches to block PKA-driven tumor growth in fibrolamellar liver cancer — Principal investigator(s): John Gordan, Nabeel Bardeesy — 2016
• Pre-clinical studies of the interactions of the immune system with FL-HCC — Principal investigator(s): Kevin Barry — 2016

This list represents the complete set of Fibrolamellar Cancer Foundation grants awarded to University of California at San Francisco.